Hamilton Point Investment Advisors LLC Buys Shares of 92,934 Vital Farms, Inc. $VITL

Key Points

• Hamilton Point Investment Advisors LLC acquired 92,934 shares of Vital Farms, Inc. valued at approximately $3.58 million, increasing its stake to 0.21% of the company.
• Insider sales included Joanne Bal selling 4,796 shares and Matthew Ohayer selling 100,000 shares, with total sales by insiders exceeding $20 million in the last ninety days.
• Several analysts have raised their target prices for Vital Farms, with BMO Capital Markets increasing its target from $50 to $60, highlighting a positive outlook on the company's performance.

Hamilton Point Investment Advisors LLC acquired a new stake in Vital Farms, Inc. (NASDAQ:VITL - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 92,934 shares of the company's stock, valued at approximately $3,580,000. Hamilton Point Investment Advisors LLC owned approximately 0.21% of Vital Farms as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of VITL. GAMMA Investing LLC lifted its stake in Vital Farms by 2,059.4% in the 1st quarter. GAMMA Investing LLC now owns 6,003 shares of the company's stock valued at $197,000 after purchasing an additional 5,725 shares during the last quarter. Rhumbline Advisers lifted its holdings in shares of Vital Farms by 1.9% during the first quarter. Rhumbline Advisers now owns 47,317 shares of the company's stock worth $1,442,000 after purchasing an additional 885 shares during the period. SG Americas Securities LLC acquired a new position in Vital Farms in the first quarter valued at $760,000. Hanson & Doremus Investment Management acquired a new position in Vital Farms in the first quarter valued at $130,000. Finally, Allspring Global Investments Holdings LLC lifted its holdings in Vital Farms by 53.2% in the first quarter. Allspring Global Investments Holdings LLC now owns 23,177 shares of the company's stock valued at $706,000 after buying an additional 8,049 shares during the period. 98.59% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Vital Farms

In other news, insider Joanne Bal sold 4,796 shares of the stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $50.95, for a total value of $244,356.20. Following the sale, the insider owned 43,332 shares of the company's stock, valued at approximately $2,207,765.40. This represents a 9.97% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Matthew Ohayer sold 100,000 shares of the stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $50.96, for a total transaction of $5,096,000.00. Following the completion of the sale, the insider directly owned 6,482,070 shares in the company, valued at approximately $330,326,287.20. This represents a 1.52% decrease in their position. The disclosure for this sale can be found here. Insiders sold 412,868 shares of company stock worth $20,894,584 in the last ninety days. Company insiders own 21.30% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on VITL shares. Mizuho boosted their target price on shares of Vital Farms from $45.00 to $53.00 and gave the company an "outperform" rating in a report on Monday, August 11th. DA Davidson lifted their price target on shares of Vital Farms from $51.00 to $52.00 and gave the company a "buy" rating in a research note on Monday, August 11th. BMO Capital Markets boosted their target price on shares of Vital Farms from $50.00 to $60.00 and gave the stock an "outperform" rating in a research report on Tuesday, September 2nd. Telsey Advisory Group upped their price objective on shares of Vital Farms from $46.00 to $50.00 and gave the stock an "outperform" rating in a research report on Friday, August 8th. Finally, Weiss Ratings cut shares of Vital Farms from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Wednesday, October 8th. Twelve investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $49.80.

Vital Farms Price Performance

Shares of VITL opened at $41.56 on Tuesday. The company has a market capitalization of $1.86 billion, a P/E ratio of 37.11 and a beta of 0.92. The company has a quick ratio of 2.10, a current ratio of 2.48 and a debt-to-equity ratio of 0.02. The firm has a 50 day moving average of $46.15 and a 200 day moving average of $38.77. Vital Farms, Inc. has a twelve month low of $27.91 and a twelve month high of $53.13.

Vital Farms (NASDAQ:VITL - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, topping analysts' consensus estimates of $0.27 by $0.09. The firm had revenue of $184.77 million during the quarter, compared to analyst estimates of $170.28 million. Vital Farms had a net margin of 7.84% and a return on equity of 18.40%. During the same period in the previous year, the business posted $0.36 earnings per share. The business's revenue for the quarter was up 25.4% on a year-over-year basis. Vital Farms has set its FY 2025 guidance at EPS. As a group, equities research analysts anticipate that Vital Farms, Inc. will post 1.11 earnings per share for the current fiscal year.

Vital Farms Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.